Situation was such that the picturesque and renowned skyline of New...
Category:
Health
Latest
AI outperforms standard risk model for predicting breast cancer: Study
''Recent advances in AI deep learning provide us with the ability...
Raising awareness about brain tumour symptoms imperative for better treatment, say docs
Dr Manish Vaish, senior director of neurosurgery at Max Super...
Labour codes to herald new wave of reforms in 2021; job creation likely to be major challenge
during the pandemic, the central government was successful in getting Parliament’s approval for three labour codes on Industrial Relations, Social Security and Occupational Health Safety & Working Conditions (OSH) this year
The Code on Wages was approved by Parliament last year and its rules have been firmed up. But the implementation of the rules for Code on Wages was held back because the government wanted to implement all four labour codes in one go
Assessing 2020:Fight against COVID-19 kept health ministry on its toes
At present, six COVID-19 vaccines are undergoing clinical trials in India.
They are: Covaxin, developed by Bharat Biotech in collaboration with ICMR; Oxford vaccine manufactured by SII under licence from AstraZeneca; ZyCOV-D being developed by Cadila Healthcare Ltd in Ahmedabad in collaboration with the Centre”s Department of Biotechnology; Sputnik V vaccine manufactured by Dr Reddy”s Lab, Hyderabad, in collaboration with Russia”s Gamaleya National Centre; one manufactured by Biological E Ltd, Hyderabad, in collaboration with MIT, US and the sixth developed by Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, US.
Besides, there is NVX-CoV2373, which is being developed by SII in collaboration with Novavax and its phase-3 clinical trial is under consideration with the drug regulator.
Coronavirus brought tourism to its knees in 2020
The tourism sector is one of the largest industries and accounts for 6.23 per cent of the country’s gross domestic product (GDP) and provides employment to 8.78 per cent of the population.
It managed to generate around 275.5 billion dollars in revenue in fiscal 2018 with an annual growth rate at 9.4 per cent.
More COVID-19 vaccines in pipeline as US ramps up effort
If you want to have enough vaccine to vaccinate all the people in the U.S. who you’d like to vaccinate up to 85 per cent or more of the population you’re going to need more than two companies,” Dr Anthony Fauci, the top US infectious disease expert, told The Associated Press on Monday.
The nation has repeatedly recorded more than 3,000 dead per day over the past few weeks.
Scientists quell concerns on new COVID-19 variant, say staying cautious sufficient
The European Centre for Disease Prevention and Control (ECDC) has said preliminary modelling results communicated by the UK on December 19 suggest the variant is 70 per cent more transmissible than previously circulating variants. However, it also said there is no indication of increased infection severity observed related to the variant with multiple mutations in the spike protein.
According to the Health Ministry, the SARS-CoV-2”s UK variant genome was detected in three samples in the National Institute of Mental Health and Neuro Sciences Hospital (NIMHANS), Bengaluru, two in the Centre for Cellular and Molecular Biology (CCMB), Hyderabad, and one in the National Institute of Virology (NIV), Pune.
No evidence that vaccines will not work against new Covid variant: Govt
Giving a break-up on the basis of the gender and age of those infected with the novel coronavirus, Union Health Secretary Rajesh Bhushan said 63 per cent of total cases in the country have been reported in males and 37 per cent cases in females.
“Eight per cent cases have been reported below the age of 17 years, 13 per cent in the 18-25 years age group, 39 per cent in 26-44 years group, 26 per cent in 45-60 years group and 14 per cent above 60 years,” he said.
Bhushan said 70 per cent of COVID deaths have been reported in men and 45 per cent fatalities due to this disease have been reported in those below 60 years of age.
India finds six cases of virus variant, to extend UK flight ban till Jan 7
Health authorities expect to start a vaccination drive for some 300 million people early next month, with the Serum Institute of India, which is making the Oxford/AstraZeneca coronavirus shot, expecting its emergency approval within days.
UK needs tighter COVID rules to avert new “catastrophe”, epidemiologist warns
“We are entering a very dangerous new phase of the pandemic, and we’re going to need decisive early national action to prevent a catastrophe in January and February,” said Andrew Hayward, professor of infectious disease epidemiology at University College London.
More than 71,000 people in Britain have died within 28 days of a positive test for the disease.
India’s financial sector faces challenging times ahead – RBI
The overall outlook for the Indian economy in 2021 continues to remain uncertain, the report said.“
Given the uncertainty induced by COVID-19 and its real economic impact, the asset quality of the banking system may deteriorate sharply going forward,” the RBI said.
The report also said Indian banks had written-off loans worth 2.38 trillion rupees ($32.46 billion) in the financial year 2020 that ended on March 31.
Wealthy hospitals rake in U.S. disaster aid for COVID-19 costs
Federal Emergency Management Agency has received nearly 2,200 aid requests from hospitals and thus far has approved about 15% of them, for a total of $894 million, the agency told Reuters. Hospitals can request more money as U.S. infections surge, and FEMA officials expect total aid awards to rise significantly.
Some health policy experts say that large and well-capitalized nonprofit systems – which typically pay no taxes – do not need the additional relief money. Among the aid applicants are some of the nation’s best-known health systems, including the Cleveland Clinic, Providence and Stanford Health Care.